V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240012461 | 240012620 | null | 80.6 | Curative (C) | 2016-03-11 | 2016-04-20 | VIOLA TRIAL | N | N | 240008306 | POMALIDOMIDE |
| 240012462 | 240008652 | 1.8 | 100 | Curative (C) | null | 2017-12-27 | FLAG | N | N | 240008316 | CYTARABINE + RITUXIMAB |
| 240012463 | 240012622 | 1.63 | 71 | Curative (C) | 2013-11-13 | 2013-11-13 | Mitoxantrone | 02 | N | 240008371 | VEDEX |
| 240012464 | 240008654 | 1.83 | null | null | 2018-04-17 | 2018-04-17 | RCEOP | N | null | 240008385 | THALIDOMIDE |
| 240012465 | 240008656 | 1.81 | 84.8 | Curative (C) | 2016-03-10 | 2016-03-27 | DHAP - R | N | N | 240008463 | R CODOX-M/ R IVAC |
| 240012466 | 240008659 | 1.88 | 95 | Curative (C) | 2015-05-11 | 2015-05-11 | DHAP - R | N | null | 240008463 | ETOPOSIDE |
| 240012467 | 240008661 | null | 70.4 | Palliative (P) | 2015-03-10 | 2015-03-10 | REMODLB TRIAL | 02 | null | 240008503 | MITOXANTRONE |
| 240012468 | 240008662 | 1.7 | 81.5 | Curative (C) | 2014-09-25 | 2014-10-30 | BENDAMUSTINE + OFATUMUMAB | N | N | 240008658 | TRIPLE INTRATHECAL |
| 240012469 | 240008664 | 1.7 | 74 | Curative (C) | 2015-06-17 | 2015-06-19 | FLUOROURACIL + RT | N | N | 240008732 | ETOPOSIDE |
| 240012470 | 240012626 | 1.74 | null | Curative (C) | 2015-08-18 | 2015-08-18 | R CODOX | N | N | 240008754 | IVAC |
| 240012471 | 240008666 | 1.66 | null | Neo-adjuvant (N) | 2013-11-03 | 2013-11-03 | IVE | N | N | 240008851 | CAV |
| 240012472 | 240008669 | 1.75 | 81.8 | Disease modification (D) | 2015-09-20 | 2016-03-27 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | N | N | 240009028 | CYTARABINE + METHOTREXATE |
| 240012473 | 240008671 | 1.84 | 82.6 | Palliative (P) | 2015-02-26 | 2015-04-10 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 01 | N | 240009075 | BCG |
| 240012474 | 240012629 | 1.72 | 68 | Curative (C) | 2015-03-25 | 2015-10-10 | IELSG 32 TRIAL | 02 | N | 240009295 | GEMCITABINE + OXALIPLATIN |
| 240012475 | 240012630 | 0 | 90.7 | Neo-adjuvant (N) | 2017-12-15 | 2018-03-27 | Lomustine | 02 | N | 240009342 | ALEMTUZUMAB |
| 240012476 | 240014492 | 1.57 | 81 | Curative (C) | 2018-02-26 | 2018-02-28 | AML16 Low Dose Cytarabine | 02 | N | 240009443 | CARBOPLATIN + DOCETAXEL |
| 240012477 | 240015427 | null | null | Disease modification (D) | 2013-03-13 | 2013-03-14 | BOSUTINIB | N | N | 240009443 | CAPECITABINE + OXALIPLATIN |
| 240012478 | 240008673 | 1.75 | 0 | Palliative (P) | 2013-11-25 | 2013-12-30 | AML17 TRIAL | N | N | 240009581 | CISPLATIN + GEMCITABINE |
| 240012479 | 240008674 | 1.61 | 57 | Disease modification (D) | 2016-02-28 | 2016-02-29 | AML 18 TRIAL | 2 | N | 240009587 | PEMBROLIZUMAB |
| 240012480 | 240008675 | 1.6 | 65 | Curative (C) | 2016-12-15 | 2016-12-16 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | N | 240009614 | CISPLATIN + FLUOROURACIL + RT |
| 240012481 | 240012631 | 1.75 | 70 | null | 2016-12-13 | 2016-12-17 | Oxaliplatin + Modified de Gramont | null | null | 240009614 | IGEV R |
| 240012482 | 240008683 | 1.62 | 47.9 | Palliative (P) | 2017-06-20 | 2017-06-20 | Cyclophosphamide+Fludara+TBI Allo | N | N | 240009712 | GEMCITABINE + OXALIPLATIN |
| 240012483 | 240008684 | 1.69 | null | null | 2016-02-12 | 2016-02-19 | CLADRIBINE | 02 | N | 240009723 | CYCLOPHOSPHAMIDE + VINBLASTINE |
| 240012484 | 240014495 | 1.6 | 44.9 | Curative (C) | 2018-08-24 | 2018-09-26 | VEDex | N | N | 240009723 | ICE-R |
| 240012485 | 240015912 | 1.54 | 57.8 | Palliative (P) | 2017-10-19 | 2017-10-19 | CODOX M | 02 | N | 240009728 | IVAC |
| 240012486 | 240015912 | 1.83 | null | Curative (C) | 2016-08-03 | 2017-01-08 | ETOPOSIDE | N | N | 240009728 | BORTEZOMIB + THALIDOMIDE |
| 240012487 | 240008686 | 1.59 | 69 | null | 2014-04-10 | 2014-04-10 | ETOPOSIDE | 02 | N | 240009832 | mEOC TRIAL |
| 240012488 | 240008686 | null | 63.4 | Palliative (P) | 2015-05-06 | 2015-05-15 | DHAP - R | N | null | 240009832 | VINBLASTINE |
| 240012489 | 240008687 | 1.49 | 75.9 | Palliative (P) | 2015-02-01 | 2015-02-22 | Temozolomide 200mg/m2 | 02 | N | 240009989 | R CODOX M |
| 240012490 | 240008690 | null | 77 | Palliative (P) | 2018-07-05 | 2018-07-17 | PEMBROLIZUMAB | 02 | N | 240010015 | IRINOTECAN + MDG |
| 240012491 | 240008691 | 1.63 | 44.7 | Adjuvant (A) | 2017-12-04 | 2017-12-30 | ICE-R | N | N | 240010103 | CYTARABINE + ETOPOSIDE |
| 240012492 | 240012639 | 1.71 | 57 | Adjuvant (A) | 2013-11-12 | 2013-11-15 | Capecitabine (21 day) + Irinotecan | 02 | N | 240010160 | RCEOP |
| 240012493 | 240012639 | 1.65 | 43 | Palliative (P) | 2017-03-07 | 2017-07-25 | Capecitabine (21days) + Carboplatin | 02 | N | 240010160 | CYTARABINE HIGH DOSE |
| 240012494 | 240012640 | 1.72 | 89.8 | Curative (C) | 2016-09-18 | 2016-09-25 | ALL UKALL2011 IndB Std Dex (PegAsp) | N | N | 240010288 | DOXORUBICIN |
| 240012495 | 240012640 | 1.8 | 79.2 | Palliative (P) | 2015-09-01 | 2015-09-01 | CHOEP - 21 days | 02 | null | 240010288 | CYCLOPHOSPHAMIDE + VINBLASTINE |
| 240012496 | 240012640 | 1.74 | null | Curative (C) | 2019-04-08 | 2019-04-08 | DARATUMUMAB | N | null | 240010288 | VINCRISTINE |
| 240012497 | 240016275 | 1.7 | 83 | Curative (C) | 2019-06-18 | 2019-06-25 | MABCUTE TRIAL | 02 | N | 240010386 | CLADRIBINE |
| 240012498 | 240008697 | 1.65 | 73 | Palliative (P) | 2013-12-26 | 2013-12-30 | GALLIUM TRIAL | 02 | Y | 240010414 | CYTARABINE HIGH DOSE |
| 240012499 | 240008698 | 1.68 | 69 | Palliative (P) | 2014-05-16 | 2014-06-07 | Topotecan IV 7 day | 2 | N | 240010430 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 240012500 | 240008699 | 1.63 | 0 | Disease modification (D) | 2017-09-11 | 2017-09-27 | Doxorubicin + Olaratumab | N | Y | 240010434 | CARBOPLATIN + DOCETAXEL |
| 240012501 | 240012643 | 1.64 | null | null | 2017-12-10 | 2017-12-10 | CARBOPLATIN + RT | N | N | 240010441 | IRINOTECAN + MDG |
| 240012502 | 240008700 | 1.56 | 60 | Curative (C) | 2018-12-01 | 2018-12-07 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 240010545 | CVD |
| 240012503 | 240012645 | 1.69 | 142 | Curative (C) | 2017-10-15 | 2017-10-27 | VINORELBINE | 02 | N | 240010556 | GEMCITABINE + VINORELBINE |
| 240012504 | 240015432 | 1.7 | null | null | 2017-03-28 | 2017-03-28 | ETOPOSIDE | 99 | N | 240010622 | DARATUMUMAB |
| 240012505 | 240008704 | 1.78 | 85.4 | Palliative (P) | 2017-11-15 | 2017-11-19 | CODOX M | N | N | 240010651 | OFATUMUMAB |
| 240012506 | 240008704 | 1.83 | 81 | Palliative (P) | 2014-12-09 | 2015-02-17 | CYTARABINE + METHOTREXATE | Y | N | 240010651 | MATRIX TRIAL |
| 240012507 | 240008704 | null | null | Palliative (P) | 2016-03-04 | 2016-12-11 | Carboplatin + Pemetrexed | N | N | 240010651 | CRIZOTINIB |
| 240012508 | 240015914 | 1.58 | 62.8 | Palliative (P) | 2016-02-16 | 2016-02-24 | DA-EPOCH-R | Y | null | 240011026 | CISPLATIN + FLUOROURACIL |
| 240012509 | 240015914 | null | null | Palliative (P) | 2015-07-30 | 2015-08-12 | MELPHALAN | N | N | 240011026 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 240012510 | 240016337 | 0 | 81.7 | Disease modification (D) | 2016-07-16 | 2016-07-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 240011053 | CTD |